AXA Distribution Holding Corporation – Trademark Portfolio

Entity Type: 03

AXA Distribution Holding Corporation holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 9 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include LIP, PLANCONNECT, NONQUALIFIED PLAN DOCTOR, and EXECUTIVE LIFE INCOME PLAN (ELIP). The owner is based in New York, NY.

1290 Avenue of the Americas

New York, NY 10104

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AXA Distribution Holding Corporation's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (9 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does AXA Distribution Holding Corporation have?

AXA Distribution Holding Corporation has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned, 2 cancelled.

What trademark classes does AXA Distribution Holding Corporation file in?

AXA Distribution Holding Corporation files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are AXA Distribution Holding Corporation's most well-known trademarks?

AXA Distribution Holding Corporation's registered trademark portfolio includes well-known marks such as LIP, PLANCONNECT, NONQUALIFIED PLAN DOCTOR, and EXECUTIVE LIFE INCOME PLAN (ELIP). These are among 5 currently registered trademarks in the portfolio.

What is AXA Distribution Holding Corporation's trademark registration success rate?

AXA Distribution Holding Corporation has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.